Display options
Cite
Miró JM, Moreno A, Mestres CA. Infective Endocarditis in Intravenous Drug Abusers. Curr Infect Dis Rep. 2003;5(4):307-316doi: 10.1007/s11908-003-0007-9.
Miró, J. M., Moreno, A., & Mestres, C. A. (2003). Infective Endocarditis in Intravenous Drug Abusers. Current infectious disease reports, 5(4), 307-316. https://doi.org/10.1007/s11908-003-0007-9
Miró, José M., et al. "Infective Endocarditis in Intravenous Drug Abusers." Current infectious disease reports vol. 5,4 (2003): 307-316. doi: https://doi.org/10.1007/s11908-003-0007-9
Miró JM, Moreno A, Mestres CA. Infective Endocarditis in Intravenous Drug Abusers. Curr Infect Dis Rep. 2003 Aug;5(4):307-316. doi: 10.1007/s11908-003-0007-9. PMID: 12866981.
Copy Download .nbib Format: NLM
Share it on

Curr Infect Dis Rep. 2003 Aug;5(4):307-316. doi: 10.1007/s11908-003-0007-9.

Infective Endocarditis in Intravenous Drug Abusers.

Current infectious disease reports

José M. Miró, Asuncion Moreno, Carlos A. Mestres

Affiliations

  1. *Infectious Diseases Service, Hospital Clinic--IDIBAPS, University of Barcelona, Villarroel, 170, 08036 Barcelona, Spain. [email protected]

PMID: 12866981 DOI: 10.1007/s11908-003-0007-9

Abstract

Infective endocarditis (IE) is one of the most severe complications in intravenous drug abusers (IVDA). IE usually involves the tricuspid valve, Staphylococcus aureus is the most common etiologic agent, and it has a relatively good prognosis. Currently, between 40% and 90% of IVDA with IE are HIV infected, and the HIV epidemic has caused a decrease in the incidence of this disease, probably due to changes in drug administration habits undertaken by addicts in order to avoid HIV transmission. This review focuses on progress made over the past few years in some aspects of IE in IVDA. The pathogenesis of tricuspid endocarditis is still unknown more than 60 years after the first series. The most important advance in antibiotic therapy is that noncomplicated S. aureus right-sided endocarditis can be successfully treated with an intravenous 2-week course of nafcillin or cloxacillin plus an aminoglycoside, although probably the aminoglycoside administration could be stopped after the first 3 to 5 days. Surgery in HIV-infected IVDA with IE does not worsen the prognosis. Considering the possibility of reinfection in IVDA, prosthetic material is usually avoided. Tricuspid valvulectomy or valve repair should be considered the technique of choice in IVDA with right-sided IE. Replacement of the tricuspid valve by a cryopreserved mitral homograft is the latest introduction into clinical practice. It provides atrioventricular competence, thereby avoiding late right heart failure. Reinfections can be treated medically with a negligible reoperation rate. Overall mortality for HIV-infected or non-HIV-infected IVDA with IE is similar. However, among HIV-infected IVDA, mortality is significantly higher in those who are most severely immunosuppressed, with CD4(+) cell counts below 200/L or with AIDS criteria.

References

  1. Ann Intern Med. 1987 Jun;106(6):833-6 - PubMed
  2. Enferm Infecc Microbiol Clin. 2000 Jun-Jul;18(6):293-4 - PubMed
  3. Antimicrob Agents Chemother. 1990 May;34(5):792-5 - PubMed
  4. Arq Bras Cardiol. 2000 Mar;74(3):217-31 - PubMed
  5. J Thorac Cardiovasc Surg. 1988 May;95(5):857-61 - PubMed
  6. Rev Esp Cardiol. 1972 Nov-Dec;25(6):555-6 - PubMed
  7. Zhonghua Nei Ke Za Zhi. 1996 Jul;35(7):455-7 - PubMed
  8. Tex Heart Inst J. 2001;28(2):96-101 - PubMed
  9. J Heart Valve Dis. 1993 Mar;2(2):125-8 - PubMed
  10. J Emerg Med. 2000 Jul;19(1):5-11 - PubMed
  11. J Heart Valve Dis. 2000 Nov;9(6):805-8; discussion 808-9 - PubMed
  12. Infect Dis Clin North Am. 2002 Sep;16(3):645-65, viii-ix - PubMed
  13. Clin Infect Dis. 2001 Jul 1;33(1):120-5 - PubMed
  14. Eur J Cardiothorac Surg. 2002 Feb;21(2):260-7 - PubMed
  15. Ann Thorac Surg. 1999 Nov;68(5):1727-30 - PubMed
  16. Infect Dis Clin North Am. 2002 Jun;16(2):273-95, vii-viii - PubMed
  17. Medicina (B Aires). 1994;54(3):193-8 - PubMed
  18. Int J STD AIDS. 1997 Feb;8(2):118-23 - PubMed
  19. J Infect. 2001 May;42(4):267-71 - PubMed
  20. Surg Forum. 1971;22:162-4 - PubMed
  21. Enferm Infecc Microbiol Clin. 1993 May;11(5):235-40 - PubMed
  22. J Heart Valve Dis. 1993 Mar;2(2):140-7 - PubMed
  23. Ann Intern Med. 1994 Dec 1;121(11):873-6 - PubMed
  24. Clin Microbiol Infect. 1998;4 Suppl 3:S27-S33 - PubMed
  25. Am J Med. 1996 Jul;101(1):68-76 - PubMed
  26. Clin Infect Dis. 1996 Jan;22(1):40-5 - PubMed
  27. J Clin Epidemiol. 1996 Oct;49(10):1149-54 - PubMed
  28. Ann Intern Med. 1988 Oct 15;109(8):619-24 - PubMed
  29. Ann Thorac Cardiovasc Surg. 2002 Dec;8(6):350-3 - PubMed
  30. J Infect Dis. 2002 Jun 15;185(12):1761-6 - PubMed
  31. Ann Intern Med. 1993 Nov 15;119(10):1017-28 - PubMed
  32. J Infect Dis. 1989 May;159(5):938-44 - PubMed
  33. Lancet. 1989 Nov 4;2(8671):1071-3 - PubMed
  34. Clin Infect Dis. 2000 Apr;30(4):633-8 - PubMed
  35. J Heart Valve Dis. 1993 Mar;2(2):129-37; discussion 138-9 - PubMed
  36. Ann Intern Med. 1996 Dec 15;125(12):969-74 - PubMed
  37. Ann Intern Med. 1982 Oct;97(4):496-503 - PubMed
  38. Thorac Cardiovasc Surg. 1992 Oct;40(5):279-82 - PubMed
  39. J Lab Clin Med. 1976 Jul;88(1):118-24 - PubMed
  40. J Heart Valve Dis. 1997 Nov;6(6):636-41 - PubMed
  41. Med Clin (Barc). 1992 Apr 11;98(14):521-6 - PubMed
  42. S Afr Med J. 1997 Jul;87(7):889-91 - PubMed
  43. Epidemiology. 1996 Nov;7(6):566-70 - PubMed
  44. J Card Surg. 1990 Mar;5(1):63-7 - PubMed
  45. Eur J Cardiothorac Surg. 1996;10(5):320-6 - PubMed
  46. Antimicrob Agents Chemother. 1990 Jun;34(6):1227-31 - PubMed
  47. Clin Microbiol Infect. 2003 Jan;9(1):45-54 - PubMed
  48. Eur J Cardiothorac Surg. 2003 Jun;23(6):1007-16; discussion 1016 - PubMed
  49. Chest. 1995 Jul;108(1):73-7 - PubMed
  50. Ann Thorac Surg. 1992 Sep;54(3):552-4 - PubMed
  51. Arch Intern Med. 1998 Oct 12;158(18):2043-50 - PubMed
  52. J Heart Valve Dis. 1999 Sep;8(5):575-7 - PubMed
  53. Circulation. 1984 Sep;70(3 Pt 2):I178-81 - PubMed
  54. Ann Intern Med. 1992 Oct 1;117(7):560-6 - PubMed
  55. Clin Infect Dis. 2000 Feb;30(2):374-9 - PubMed
  56. AIDS. 1996 Oct;10(12):1407-14 - PubMed
  57. J Thorac Cardiovasc Surg. 1994 Jun;107(6):1460-3 - PubMed
  58. Ann Thorac Surg. 2001 Jan;71(1):105-9 - PubMed
  59. J Acquir Immune Defic Syndr. 2000 Aug 15;24(5):483-7 - PubMed
  60. J Med Assoc Thai. 1991 Aug;74(8):313-22 - PubMed
  61. Ann Thorac Surg. 2002 Feb;73(2):467-73 - PubMed
  62. J Infect Dis. 1975 Apr;131(4):367-75 - PubMed
  63. Tex Heart Inst J. 2000;27(4):356-60 - PubMed
  64. Clin Invest Med. 2002 Aug;25(4):118-25 - PubMed
  65. Ann Thorac Surg. 1993 May;55(5):1104-7; discussion 1107-8 - PubMed
  66. JAMA. 1995 Dec 6;274(21):1706-13 - PubMed
  67. J Infect Dis. 2002 Dec 1;186(11):1677-81 - PubMed
  68. Antimicrob Agents Chemother. 1995 Feb;39(2):525-8 - PubMed
  69. J Infect Dis. 1990 Oct;162(4):967-70 - PubMed
  70. Am J Med. 1994 Mar;96(3):200-9 - PubMed
  71. J Thorac Cardiovasc Surg. 1981 Nov;82(5):684-91 - PubMed
  72. Klin Med (Mosk). 2000;78(8):47-51 - PubMed
  73. Chest. 1990 Jul;98(1):200-5 - PubMed
  74. Am J Med. 1985 Jun 28;78(6B):138-48 - PubMed
  75. Rev Clin Esp. 1994 Jul;194(7):535-9 - PubMed

Publication Types